Duodopa
| Duodopa (EU,Japan), Duopa (US), (ABT-SLV187) is a first line therapy for advanced Parkinson's disease patients with severe motor fluctuations, when conventional oral therapy is not effective. |
Type of Molecule
Small MoleculeTarget
DopamineProduct Type
New Indication| Potential Indication | Region | Phase (1, 2, 3, Submitted, Approved) |
|---|---|---|
| Parkinson's Disease | US, EU, JPN |
Approved
|